Department of Oral and Maxillofacial Radiology, Peking University School and Hospital of Stomatology, National Engineering Laboratory for Digital and Material Technology of Stomatology, and Beijing Key Laboratory of Digital Stomatology, Beijing, China.
Laryngoscope. 2020 Oct;130(10):2360-2365. doi: 10.1002/lary.28361. Epub 2019 Nov 6.
OBJECTIVES/HYPOTHESIS: To suggest a strategy for transoral removal of hilar and intraparenchymal submandibular stones.
Retrospective case series.
Retrospective evaluation was performed for 514 consecutive patients with hilar and intraparenchymal submandibular stones treated via endoscopy-assisted surgery from January 2006 to June 2018. Three patients had bilateral stones. The stones were classified as: hilar (type I), posthilar (type II), intraparenchymal (type III), and multiple stones (type IV).
The affected glands included 311 with type I, 84 with type II, 65 with type III, and 57 with type IV stones. Stones were successfully removed in 478 glands (92.5%, 478/517). Main treatment techniques included hilum ductotomy in 311 glands, intraparenchymal ductotomy in 68, submandibulotomy in 14, intraductal retrieval in 74, and hilum ductotomy accompanied by intraductal retrieval in 11. At a mean 40-months follow-up of 478 successful cases, clinical outcomes were good in 425, fair in 27, and poor in 26 glands. Postoperative sialograms in 75 stone-free patients were categorized as: type I, normal (n = 6); type II, ectasia or stenosis in the main duct and no persistent contrast on functional films (n = 44); type III, ectasia or stenosis in the main duct and mild contrast retention (n = 15); and type IV, poor shape of the main duct and evident contrast retention (n = 10). Postoperative sialometry of 32 patients revealed no significant differences of the gland function between the two sides.
Appropriate use of various endoscopy-assisted approaches helps preserve the gland and facilitates recovery of gland function in patients with different depths of hilo-parenchymal submandibular stones.
4 Laryngoscope, 130:2360-2365, 2020.
目的/假设:提出一种经口切除下颌下腺门部和腺内结石的策略。
回顾性病例系列研究。
对 2006 年 1 月至 2018 年 6 月期间接受内镜辅助手术治疗的 514 例下颌下腺门部和腺内结石患者进行回顾性评估。其中 3 例患者为双侧结石。结石分为:门部(I 型)、门后(II 型)、腺内(III 型)和多发结石(IV 型)。
受累腺体中,I 型 311 个,II 型 84 个,III 型 65 个,IV 型 57 个。478 个腺体(92.5%,478/517)中的结石均成功取出。主要治疗技术包括 311 个腺体的门部导管切开术、68 个腺体的腺内导管切开术、14 个腺体的下颌下切开术、74 个腺体的腔内取石术和 11 个腺体的门部导管切开术联合腔内取石术。对 478 例成功病例进行平均 40 个月的随访,结果为:425 例临床疗效良好,27 例中等,26 例差。75 例结石清除患者的术后唾液腺造影结果为:I 型,正常(n=6);II 型,主导管扩张或狭窄,功能片上无持续对比剂(n=44);III 型,主导管扩张或狭窄,轻度对比剂潴留(n=15);IV 型,主导管形态不良,对比剂明显潴留(n=10)。32 例患者术后涎量测定显示两侧腺体功能无显著差异。
适当使用各种内镜辅助方法有助于保留腺体,并促进不同深度下颌下腺门-腺内结石患者的腺体功能恢复。
4 级 喉镜 130:2360-2365,2020 年。